MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Prokarium

News headline image
Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy
From Prokarium
Via Business Wire
News headline image
Prokarium Appoints Ibs Mahmood as Chief Executive Officer
From Prokarium
Via Business Wire
News headline image
Prokarium Expands IP Portfolio With Two New U.S. Patents Strengthening Its Position in Bladder Cancer
From Prokarium
Via Business Wire
News headline image
Prokarium Achieves Milestone with First Patient Dosing in PARADIGM-1 Non-Muscle Invasive Bladder Cancer Clinical Trial
From Prokarium
Via Business Wire
News headline image
Prokarium Achieves Major Milestone with FDA's IND Approval for Bladder Cancer Program
From Prokarium
Via Business Wire
News headline image
Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform
From Prokarium
Via Business Wire
News headline image
Prokarium Strengthens Patent Position Through Notice of Allowance of US Patent for Immunotherapy Prime in Combination with Cell Therapies
From Prokarium
Via Business Wire
News headline image
Prokarium Expands R&D Capabilities with London Biofoundry to Deepen Microbial Immunotherapy Pipeline
From Prokarium
Via Business Wire
News headline image
Prokarium Shares Preclinical Proof-of-Concept Data on Its Microbial Immunotherapy Bladder Cancer Program at SITC 2021
From Prokarium
Via Business Wire
News headline image
Prokarium Promotes Livija Deban to Chief Scientific Officer to Drive Pipeline Expansion in Cancer Immunotherapy
From Prokarium
Via Business Wire
News headline image
Prokarium Appoints Industry Veteran Thomas Eldered as Chairman of the Board
From Prokarium
Via Business Wire
News headline image
Prokarium Appoints Uz Stammberger as Chief Medical Officer to Drive Clinical Development in Oncology
From Prokarium
Via Business Wire
News headline image
Prokarium Appoints Kristen Albright as Chief Executive Officer
From Prokarium
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story